Arrowstreet Capital’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Arrowstreet Capital’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-60,771	Closed	-$2.51M	–	1618
2015 Q2	$2.51M	Buy	+60,771	New	+$2.18M	0.01%	591
2015 Q1	–	Sell	-22,111	Closed	-$710K	–	1379
2014 Q4	$710K	Buy	+22,111	New	+$639K	﹤0.01%	970

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Arrowstreet Capital's BRLI Position: Q3 2015 in Review

Arrowstreet Capital sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 60,771 shares — an estimated $2.51M sold.

Arrowstreet Capital first reported a position in BRLI in Q4 2014 and held it in 2 quarters. The position peaked at $2.51M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Arrowstreet Capital reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Arrowstreet Capital sold 60,771 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.51M.
Arrowstreet Capital first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 2 quarters.
Arrowstreet Capital's BIO-REFERENCE LABS INC-NEW- position peaked at $2.51M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.